Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

Abstract

Background: Liquid chromatography-tandem mass spectrometry (LC/MS/MS) is a powerful technique for the simultaneous determination of cyclosporin A, tacrolimus, sirolimus and everolimus in whole blood. LC/MS/MS has the benefits of lower detection limits, greater specificity and a broader dynamic range than commercial immunoassays. This paper evaluates the use of a commercially available kit from Recipe GmbH of whole blood calibrators and controls with a quick and simple sample preparation method for LC/MS/MS determination of four immunosuppressants.
Material/Methods: Samples were prepared by adding 200 μL of protein precipitation reagent containing internal standards to 100 μL of whole blood (unknown, calibrators and controls). Samples were then vortexed and centrifuged. Two-dimensional chromatography was performed on the supernatant, with detection by LC/MS/MS using multiple reaction monitoring (MRM) in positive mode. Mass spectrometer parameters were optimized for each analyte.
Results: The whole blood calibrator kit contained 7 calibrators including a blank. The LC/MS/MS assay showed excellent linearity over the concentration range with calibration regression coefficient ranging from 0.9994 to 0.9998. The intra-assay accuracy and precision was within the 20% cutoff, with the exception of the lowest concentration calibrator. Inter-assay accuracy ranged from 89-102% for the low concentration quality control, with % CVs ranging from 5.5-17%. Unknown sample results show good correlation with results obtained from a separate laboratory that prepares their own calibrators and controls in-house.
Conclusions: This study has demonstrated the successful use of a commercially available kit for whole blood calibrators and controls for the determination of four immunosuppressants in unknown samples by LC/MS/MS.

Keywords: Chromatography, immunosuppressants, Sirolimus

Add Comment 0 Comments

In Press

Case report  

Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case Series

Ann Transplant In Press; DOI: 10.12659/AOT.951715  

Original article  

Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.952251  

Original article  

The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...

Ann Transplant In Press; DOI: 10.12659/AOT.952031  

Original article  

Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...

Ann Transplant In Press; DOI: 10.12659/AOT.953143  

Most Viewed Current Articles

24 Aug 2021 : Review article   20,545

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article   16,641

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

05 Apr 2022 : Original article   15,898

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   15,796

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358